| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|
| Income (loss) from operations | -8,782 | 457,704 | 426,798 | |
| Net income (loss) | -8,782 | 457,704 | 426,798 | |
| Net loss per common share - basic (in dollars per share) | 0 | 0.01 | 0.01 | |
| Net loss per common share - diluted (in dollars per share) | 0 | 0.01 | 0.01 | |
| Weighted average common shares outstanding - basic (in shares) | 10,979,055 | 43,916,221 | 43,916,221 | |
| Weighted average common shares outstanding - diluted (in shares) | 10,979,055 | 44,336,221 | 44,336,221 | |
BioScience Health Innovations, Inc. (BHIC)
BioScience Health Innovations, Inc. (BHIC)